View |
|
DRP-10891
|
Ondansetron (as hydrochloride)
|
Nauzex
|
2 mg/mL (8 mg/4 mL)
|
Solution for Injection (IM/IV)
|
Antiemetic (5-HT3-Receptor Antagonist)
|
Aroma İlaç San. Ltd. Şti
|
Turkey
|
Initial
|
14 December 2021
|
14 December 2026
|
View |
|
DRP-10892
|
Zolendronic Acid (Monohydrate)
|
Ossi
|
800 mcg/mL (4 mg/5 mL)
|
Concentrated Solution for
Injection (IV Infusion)
|
Bisphosphonates
|
Aroma İlaç San. Ltd.
|
Turkey
|
Initial
|
14 December 2021
|
14 December 2026
|
View |
|
DRP-10900
|
Levetiracetam
|
Lepstop
|
100 mg/mL (500 mg/5 mL)
|
Concentrated Solution for
Injection (IV Infusion)
|
Antiepilectic
|
Aroma İlaç San. Ltd.
|
Turkey
|
Initial
|
14 December 2021
|
14 December 2026
|
View |
|
DR-XY31035
|
Omeprazole (as sodium)
|
None
|
40 mg
|
Lyophilized Powder for Injection (I.V.)
|
-
|
Standard Chem. & Pharm. Co., Ltd.
|
Taiwan
|
-
|
07 December 2021
|
01 September 2025
|
View |
|
DR-XY20125
|
Thiamine Hydrochloride/Fluid Extract of Tiki-Tiki/Fluid
Extract of Cinchona/Fluid Extract of Cola/Alcohol
|
ino de Quina/La Carmina
|
Each 350mL contains: Thiamine Hydrochloride Fluid Extract of Tiki-Tiki Fluid Extract of Cinchona Fluid Extract of Cola Alcohol
200 mg 0.75 mL 0.65 mL 0.65 mL 52.50 mL
|
Syrup
|
-
|
Ace Pharmaceuticals, Inc.
|
Philippines
|
-
|
07 December 2021
|
17 July 2025
|
View |
|
DRP-1203
|
Iron + Folic Acid
|
Hemiron
|
60 mg (equivalent to 200 mg Ferrous Sulfate) /400mcg
|
Capsule
|
-
|
Ace Pharmaceuticals, Inc.
|
Philippines
|
-
|
03 December 2021
|
18 July 2025
|
View |
|
DRP-1078
|
Enalapril Maleate
|
Scheepril
|
20 mg
|
Tablet
|
-
|
Scheele Laboratories Phils., Inc.
|
Philippines
|
Renewal (Revalidation)
|
03 December 2021
|
06 July 2027
|
View |
|
DRP-10894
|
Co-Amoxiclav
|
Clavoxsur
|
1 g/200 mg
|
Powder for Injection (IM/IV)
|
Antibacterial (Penicillin)
|
Reyoung Pharmaceutical Co., Ltd.
|
China
|
Initial
|
09 February 2022
|
14 December 2026
|
View |
|
DRP-3703
|
Citicoline
|
Citicomed
|
250 mg/mL (1 g/4 mL)
|
Solution for Injection (I.M./I.V.)
|
-
|
Medchem International Limited
|
India
|
Automatic Renewal (Re-Issuance)
|
09 March 2023
|
15 September 2025
|
View |
|
DRP-10854
|
Diclofenac Sodium
|
Diclozed
|
25 mg/ mL
|
Solution for Injection (IM/IV)
|
Non-Steroidal Anti-inflammatory Drug
(NSAID)/Antirheumatic
|
Sakar Healthcare Pvt. Ltd.
|
India
|
Initial
|
09 December 2021
|
09 December 2026
|
View |
|
BRP-100
|
Epoetin Alfa
|
Epiao
|
4000 IU/mL
|
Solution for Injection (IV/SC)
|
Antianemic Preparations
|
Shenyang Sunshine Pharmaceutical Co., Ltd.
|
China
|
Initial
|
14 December 2021
|
14 December 2026
|
View |
|
DRP-10830
|
Ketoanalogues + Essential Amino Acid
|
Globisaph
|
Each film-coated tablet contains: Calcium-4-methyl-2-oxo-valerate (a-ketoanalogue to leucine, calcium salt)................. .... 101 mg Calcium-3-methyl-2-oxo-butyrate (a-ketoanalogue to valine, calcium salt)................... ....86 mg Calcium-2-oxo-3-phenylpropionate (a-ketoanalogue to phenylalanine, calcium salt)........ 68 mg Calcium-3-methyl-2-oxo-valerate (a-ketoanalogue to isoleucine, calcium salt)................... Calcium-DL-2-hydroxy-4-methylthio) butyrate (a-hydroxyanalogue to methionine, calcium salt)...............59 mg
L-Histidine...........
.......38 mg
L-Tyrosine........
.......30 mg
67 mg
L-Tryptophan.......
.......23 mg
|
Film-Coated Tablet
|
-
|
Sapphire Lifesciences Pvt. Ltd.
|
India
|
Initial (Re-Issuance)
|
18 August 2022
|
03 December 2026
|
View |
|
DR-XY35960
|
Levofloxacin (as hemihydrate)
|
Lexyl-OD
|
750 mg
|
Film-Coated Tablet
|
Antibacterial (Quinolone)
|
Lloyd Laboratories, Inc.
|
Philippines
|
Renewal
|
16 March 2024
|
05 June 2029
|
View |
|
DRP-078
|
Cimetidine
|
Lemecit
|
200 mg
|
Tablet
|
H-2 Receptor Antagonist
|
Diamond Laboratories Inc.
|
Philippines
|
-
|
10 December 2021
|
08 January 2027
|
View |
|
DRP-10047
|
Prednisone
|
Prend
|
10 mg/ 5 mL
|
Suspension
|
Corticosteroid
|
Lloyd Laboratories, Inc.
|
Philippines
|
Automatic Renewal
|
25 May 2023
|
07 August 2028
|
View |
|
DRP-8962-01
|
Doxorubicin Hydrochloride
|
Doxstar 10
|
10 mg
|
Lyophilized Powder For IV Injection/Infusion
|
Antineoplastic (Anthracycline and related substances)
|
ADMAC Lifesciences
|
India
|
Automatic Renewal
|
29 May 2023
|
08 August 2028
|
View |
|
DR-XY38006
|
Mefenamic Acid
|
Mefejal Forte
|
500 mg
|
Capsule
|
Non-steroidal Anti-inflammatory Drug (NSAID)
|
Lejal Laboratories, Inc.
|
Philippines
|
Renewal
|
23 May 2022
|
28 May 2027
|
View |
|
DR-2414
|
Furazolidone
|
F-Zolidone
|
100 mg
|
Tablet
|
Antibacterial / Antiprotozoal
|
Lejal Laboratories, Inc.
|
Philippines
|
Renewal
|
25 May 2022
|
21 May 2027
|
View |
|
DRP-5247
|
Clonidine Hydrochloride
|
None
|
150 mcg
|
Tablet
|
Antihypertensive
|
Drugmaker's Laboratories, Inc.
|
Philippines
|
Automatic Renewal
|
22 August 2022
|
06 December 2027
|
View |
|
DR-XY36954
|
Acetated Ringer's Solution
|
None
|
FORMULATION:
Each 100 mL contains:
Sodium Chloride
600 mg Sodium Acetate
380 mg Potassium Chloride
30 mg
Calcium Chloride
20 mg
|
Solution for Intravenous Infusion
|
Parenteral
|
A.N.B. Laboratories Co., Ltd.
|
Thailand
|
Initial (Variation)
|
26 March 2024
|
26 March 2029
|